Market Capitalization (Millions $) |
43 |
Shares
Outstanding (Millions) |
39 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-71 |
Cash Flow (TTM) (Millions $) |
-93 |
Capital Exp. (TTM) (Millions $) |
8 |
Achilles Therapeutics Plc
Achilles Therapeutics Plc is a biopharmaceutical company that specializes in the development of personalized cancer immunotherapies. The company utilizes a unique approach called Tumor Microenvironment Targeting to identify and target specific cancer mutations that are unique to each patient. This approach allows Achilles Therapeutics to create personalized, cell-based immunotherapies that can potentially improve the treatment outcomes for patients with solid tumors. The company's therapies aim to stimulate the patient's immune system to recognize and destroy cancer cells. Achilles Therapeutics Plc is based in the United Kingdom and is listed on the London Stock Exchange under the ticker symbol ACHL.
Company Address: 245 Hammersmith Road London 0
Company Phone Number: (0)20 8154 4600 Stock Exchange / Ticker: NASDAQ ACHL
|